Emkay Global Financial Services has reiterated its BUY recommendation on Life Insurance Corporation of India (LIC), while raising the target price to Rs1,100 from Rs1,000 after the insurer delivered a materially stronger-than-expected Q4FY26 performance. The brokerage highlighted a sharp expansion in Value of New Business (VNB) margins, robust Annualized Premium Equivalent (APE) growth, and sustained traction in high-margin non-participating products as key drivers behind the upgrade. LIC’s improving product mix, expanding ticket sizes, and disciplined profitability focus have strengthened investor confidence despite volatility linked to solvency regulations and market-linked investments. Emkay believes the insurer is entering a structurally stronger earnings cycle, supported by accelerating VNB growth, rising embedded value, and improving operating efficiency.

Emkay Raises Conviction on LIC After Margin-Led Earnings Beat

LIC surprised the Street with a powerful profitability-driven quarter. The insurer reported Q4FY26 APE of Rs229.5 billion, representing a year-on-year growth of 21.8%, comfortably ahead of Emkay’s estimate of Rs212.8 billion. More importantly, the VNB margin surged to 25.7%, expanding by 6.9 percentage points compared with the same quarter last year. This performance significantly exceeded brokerage expectations of 20.5%.

The sharp rise in profitability translated into Q4FY26 VNB of Rs58.9 billion, marking a massive 66.7% year-on-year jump. For the full FY26 period, LIC posted VNB of Rs141.8 billion, up 41.6% YoY, while annual VNB margins improved to 21.2% from 17.6% a year earlier.

Non-Par Products Emerging as the Core Profit Engine

The insurer’s evolving product mix is becoming the centerpiece of its profitability transformation. According to management commentary, the non-participating product segment contributed nearly 53% of overall VNB during FY26, substantially strengthening margin quality. The participating business contributed 28%, while the group business accounted for the remaining 19%.

LIC’s Individual Non-Par mix expanded to nearly 23% of total APE, a major structural shift compared with historical levels. The management emphasized that favorable product mix changes alone contributed roughly 3% toward VNB margin expansion during FY26, while movement in the risk-free yield curve added another 3.4%.

The company also highlighted strong traction in high-ticket policies, particularly through products such as Jeevan Utsav and Jeevan Labh, which have enhanced both premium growth and policy persistency.

APE Growth Remains Robust Despite Product Consolidation

Even as LIC rationalizes its product portfolio, growth momentum remains intact. The insurer delivered FY26 APE growth of 17.8% to Rs669.6 billion. Individual APE increased 13.4%, while group APE rose an impressive 27% YoY.

Management indicated that while product mix consolidation may moderate certain growth pockets, the overarching strategy remains focused on expanding absolute VNB rather than merely maximizing margins.

Persistency Trends Remain a Key Monitoring Variable

Despite strong operational momentum, persistency performance showed mixed signals. The 13th-month persistency ratio remained relatively stable at 74.6%, while the 61st-month persistency ratio declined to 59.3% from 63.1% a year earlier.

Management acknowledged that certain business lines witnessed adverse persistency and expense assumptions, contributing negatively to embedded value operating variances. However, the company expects higher-ticket policies and improved agent productivity to gradually strengthen retention metrics over time.

The insurer also plans to focus aggressively on younger agent recruitment, training programs, and productivity enhancement initiatives to stabilize long-term policy renewal behavior.

Solvency Position Reflects Conservative Capital Strategy

LIC’s management remains cautious ahead of the transition toward a Risk-Based Solvency framework. The solvency ratio improved significantly to 235% from 211% last year. However, the management indicated that higher exposure to participating products and equity-linked investments could create larger capital requirements under the upcoming regulatory structure.

This conservative stance also influenced dividend policy decisions. LIC declared a final dividend of Rs10 per share on the post-bonus basis, while simultaneously preserving capital buffers for future profitable growth opportunities.

The management repeatedly stressed that maintaining solvency resilience remains a strategic priority given the evolving regulatory environment.

Brokerage Revises Forecasts Upward Across Key Metrics

Emkay materially upgraded its forward estimates following the strong quarterly performance. The brokerage increased FY27-FY28 APE estimates by roughly 4-5%, while raising VNB margin assumptions by 200-240 basis points.

The revised projections now imply FY28 embedded value of Rs9.64 trillion and FY29 EV crossing Rs10.68 trillion.

Valuation Still Appears Attractive Relative to Growth Outlook

Despite improving fundamentals, LIC continues to trade at inexpensive valuation multiples. Emkay’s revised target price of Rs1,100 implies an FY28E Price-to-Embedded Value multiple of just 0.7x.

At the current market price of approximately Rs800, the stock offers an upside potential of nearly 37.5%, according to the brokerage. Forward valuation metrics remain relatively undemanding, with FY27E P/E estimated at 7.6x and P/EV at 0.6x.

The brokerage believes the market is still underappreciating LIC’s structural transition toward higher-margin products and improving operational profitability.

Investment Outlook and Key Levels for Investors

LIC appears to be transitioning from a legacy volume-driven insurer into a profitability-focused life insurance franchise. The strong acceleration in non-par products, rising ticket sizes, expanding VNB margins, and improving solvency profile collectively reinforce the long-term investment thesis.

From a trading and investment perspective:

• Current Market Price: Rs800
• Target Price: Rs1,100
• Potential Upside: 37.5%
• Key Support Zone: Rs720-Rs750
• Medium-Term Resistance: Rs900-Rs980

While regulatory changes linked to solvency capital requirements and market volatility in equity investments remain important risks, LIC’s operational trajectory suggests improving profitability visibility over the next two to three years.

For long-term investors seeking exposure to India’s expanding insurance penetration story, LIC may increasingly evolve into a compelling value-plus-growth opportunity as margin expansion continues to gain momentum.